106 related articles for article (PubMed ID: 27069130)
21. Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer.
Liu PL; Tsai JR; Chiu CC; Hwang JJ; Chou SH; Wang CK; Wu SJ; Chen YL; Chen WC; Chen YH; Chong IW
Mol Carcinog; 2010 Oct; 49(10):874-81. PubMed ID: 20607726
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
23. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
24. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth.
Schmidt LH; Spieker T; Koschmieder S; Schäffers S; Humberg J; Jungen D; Bulk E; Hascher A; Wittmer D; Marra A; Hillejan L; Wiebe K; Berdel WE; Wiewrodt R; Muller-Tidow C
J Thorac Oncol; 2011 Dec; 6(12):1984-92. PubMed ID: 22088988
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of eukaryotic elongation factor 1 alpha-2 in non-small cell lung cancer.
Kawamura M; Endo C; Sakurada A; Hoshi F; Notsuda H; Kondo T
Anticancer Res; 2014 Feb; 34(2):651-8. PubMed ID: 24510995
[TBL] [Abstract][Full Text] [Related]
26. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
27. The clinical and pathological significance of RCAS1 expression as a prognostic biomarker in non-small cell lung cancer.
Tsoukalas N; Kostakis ID; Siakavellas S; Giaginis C; Bournakis E; Sfiniadakis I; Karameris A; Patsouris E; Theocharis S
In Vivo; 2014; 28(3):375-81. PubMed ID: 24815841
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
30. Functional expression of the voltage-gated Na⁺-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells.
Campbell TM; Main MJ; Fitzgerald EM
J Cell Sci; 2013 Nov; 126(Pt 21):4939-49. PubMed ID: 23986482
[TBL] [Abstract][Full Text] [Related]
31. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract][Full Text] [Related]
32. SCUBE3 overexpression predicts poor prognosis in non-small cell lung cancer.
Zhao C; qin Q; Wang Q; Zhang J; Xu Y; Li W; Gu M; Chen S; Deng A
Biosci Trends; 2013 Dec; 7(6):264-9. PubMed ID: 24390364
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer.
Lo FY; Chen HT; Cheng HC; Hsu HS; Wang YC
Lung Cancer; 2012 Sep; 77(3):585-92. PubMed ID: 22749159
[TBL] [Abstract][Full Text] [Related]
34. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.
Shimizu K; Yoshida J; Nagai K; Nishimura M; Ishii G; Morishita Y; Nishiwaki Y
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):160-5. PubMed ID: 15999057
[TBL] [Abstract][Full Text] [Related]
35. FOXD1 expression is associated with poor prognosis in non-small cell lung cancer.
Nakayama S; Soejima K; Yasuda H; Yoda S; Satomi R; Ikemura S; Terai H; Sato T; Yamaguchi N; Hamamoto J; Arai D; Ishioka K; Ohgino K; Naoki K; Betsuyaku T
Anticancer Res; 2015 Jan; 35(1):261-8. PubMed ID: 25550559
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
37. [Expression and clinical significance of BCL6 corepressor-like 1 in non-small cell lung cancer].
Zhao X; Tuo H; Si M; Wang L; Liang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1677-81. PubMed ID: 26648304
[TBL] [Abstract][Full Text] [Related]
38. Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs).
Pircher A; Fiegl M; Untergasser G; Heidegger I; Medinger M; Kern J; Hilbe W
Lung Cancer; 2013 Aug; 81(2):252-8. PubMed ID: 23664449
[TBL] [Abstract][Full Text] [Related]
39. The inhibition of aromatase alters the mechanical and rheological properties of non-small-cell lung cancer cell lines affecting cell migration.
Giannopoulou E; Siatis KE; Metsiou D; Kritikou I; Papachristou DJ; Kalofonou M; Koutras A; Athanassiou G; Kalofonos HP
Biochim Biophys Acta; 2015 Feb; 1853(2):328-37. PubMed ID: 25450981
[TBL] [Abstract][Full Text] [Related]
40. TGFβ-induced cytoskeletal remodeling mediates elevation of cell stiffness and invasiveness in NSCLC.
Gladilin E; Ohse S; Boerries M; Busch H; Xu C; Schneider M; Meister M; Eils R
Sci Rep; 2019 May; 9(1):7667. PubMed ID: 31113982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]